ORIGINAL PAPER
Evaluation of warning signs of primary immunodeficiencies
 
More details
Hide details
1
Department of Children’s Diseases and Paediatric Surgery, I. Horbachevsky Ternopil National Medical University, Ternopil, Ukraine
 
2
Bogomolets National Medical University, Kyiv, Ukraine
 
 
Submission date: 2019-08-07
 
 
Final revision date: 2019-11-03
 
 
Acceptance date: 2019-11-15
 
 
Publication date: 2019-12-31
 
 
Pediatr Pol 2019;94(6):337-341
 
KEYWORDS
TOPICS
ABSTRACT
Introduction:
Primary immunodeficiencies (PID) are a group of more than 350 rare diseases, which are characterised by a variety of clinical symptoms and are difficult to diagnose. Early diagnosis is very important for improvement of quality of life of the children with PID. The aim of the study was to evaluate the warning signs of PID, taking into account the regional features of PID prevalence to improve early verification of these disorders.

Material and methods:
Overall, 107 children aged between two months and 18 years with warning signs of PID, developed by the Jeffrey Modell Foundation Medical Advisory Board, as well as with other warning signs of PID, developed by the Ukrainian Association of Pediatric Immunology, were enrolled in the study. The patients were referred to immunologists by primary care physicians or hospital specialists during the implementation of physician education and a public awareness program of early diagnosis and management of PID.

Results:
Among 107 children with warning signs, PID was diagnosed in 19 (17.8%) patients. Chronic diarrhoea with malabsorption was present more frequently in the patients with definable PID (p = 0.0048). Dysmorphic features and/or microcephaly were also more common in the patients with PID (p = 0.0456). More significant differences were found when microcephaly was combined with dysmorphic features (p = 0.0004). Congenital heart disease occurred only in the patients with PID (p = 0.0437), in particular with DiGeorge (22q11.2 deletion) syndrome.

Conclusions:
For early detection of PID, it is necessary to take into account regional features of the prevalence of certain PID. Our study has established that such warning signs as chronic diarrhoea with malabsorption, dysmorphic features and microcephaly, and congenital heart disease with/or without seizures with underlying hypocalcaemia were important for PID diagnosis in the studied region.
REFERENCES (20)
1.
Gathman B, Grimbacher B, Beaute J, et al. The European internet-based patient and research database for primaryimmunodeficiencies: results 2006–2008. Clin Exp Immunol 2009; 157 (Suppl 1): 3-11.
 
2.
Eades‐Perner A, Gathmann B, Knerr V, et al. The European internet‐based patient and research database for primary immunodeficiencies: results 2004–06. Clin Exp Immunol 2007; 147: 306-312.
 
3.
Subbarayan A, Colarusso G, Hughes SM, et al. Clinical features that identify children with primary immunodeficiency diseases. Pediatrics 2011; 127: 810-816.
 
4.
Modell V, Orange JS. Quinn J, Modell F. Global report on primary immunodeficiencies: 2018 update from the Jeffrey Modell Centers Network on disease classification, regional trends, treatment modalities, and physician reported outcomes. Immunol Res 2018; 66: 367-380.
 
5.
King JR, Hammarström L. Newborn Screening for Primary Immunodeficiency Diseases: History, Current and Future Practice. J Clin Immunol 2018; 38: 56-66.
 
6.
Pessach I, Walter J, Notarangelo LD. Recent advances in primary immunodeficiencies: identification of novel genetic defects and unanticipated phenotypes. Pediatr Res 2009; 6: 3-12.
 
7.
Marodi L, Notarangelo LD. Immunological and genetic bases of new primary immunodeficiencies. Nat Rev Immunol 2007; 7: 851-861.
 
8.
Boyarchuk O, Lewandowicz-Uszyńska A, Kinash M, et al. Physicians’ awareness concerning primary immunodeficiencies in the Ternopil Region of Ukraine. Pediatr Pol 2018; 93: 221-228.
 
9.
INFO4PI.org. Primary immunodeficiency resource center. Available at: www.info4pi.org (access: 30 June 2019).
 
10.
Marodi L, Casanova JL. Novel primary immunodeficiencies relevant to internal medicine: novel phenotypes. J Intern Med 2009; 266: 502-506.
 
11.
Boyarchuk O. Allergic manifestations of primary immunodeficiency diseases and its treatment approaches. Asian J Pharm Clin Res 2018; 11: 83-90.
 
12.
Galal N, Ohida M, Meshaal S, et al. Targeted screening for primary immunodeficiency disorders in the neonatal period and early infancy. Afri Health Sci 2019; 19: 1449-1459.
 
13.
Arkwright PD, Gennery AR. Ten warning signs of primary immunodeficiency: a new paradigm is needed for the 21st century. Ann N Y Acad Sci 2011; 1238: 7-14.
 
14.
ESID Registry – Working Definitions for Clinical Diagnosis of PID. Available at: https://esid.org.
 
15.
Varon R, Seemanova E, Chrzanowska K, et al. Clinical ascertainment of Nijmegen breakage syndrome (NBS) and prevalence of the major mutation, 657del5, in three Slav populations. Eur J Hum Genet 2000; 8: 900-902.
 
16.
Boyarchuk O, Volyanska L, Dmytrash L. Clinical variability of chromosome 22q11.2 deletion syndrome. Cent Eur J Immunol 2017; 42: 412-417.
 
17.
Alvarez-Cardona A, Espinosa-Padilla SE, Reyes SOL, et al. Primary Immunodeficiency Diseases in Aguascalientes, Mexico: Results from an Educational Program. J Clin Immunol 2016; 36: 173-178.
 
18.
Boyarchuk O, Volyanska L, Kosovska T, et al. Awareness about primary immunodeficiency diseases among medical students. Georgian Med News 2018; 12: 124-130.
 
19.
Boyarchuk O, Kinash M, Hariyan T, Bakalyuk T. Evaluation of knowledge about primary immunodeficiencies among postgraduate medical students. Arch Balk Med Union 2019; 54: 11-19.
 
20.
Pac M, Bernatowska E. Comprehensive activities to increase recognition of primary immunodeficiency and access to immunoglobulin replacement therapy in Poland. Eur J Pediatr 2016; 175: 1099.
 
Journals System - logo
Scroll to top